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ABSTRACT 
The mechanism(s) linking physical inactivity, obesity, and type-II diabetes are unclear. I 
hypothesized low intrinsic aerobic capacity is associated with reduced systemic insulin 
sensitivity via skeletal muscle insulin signaling. After 34 generations of selective 
breeding, high aerobic capacity (HCR) rats exhibited an 8-fold increase in running 
distance vs low aerobic capacity (LCR) rats (n=14 per group). LCR rats had higher rates 
of weight gain vs HCR (p<0.05) though food consumption was constant (p=0.86) over a 
12-week study. Rats were divided into 4 groups:  1) LCR-Sham Surgery, 2) LCR-
Catheterization, 3) HCR-Sham Surgery or 4) HCR-Catheterization (n=7 per group).  
Euglycemic-hyperinsulinemic clamps on catheterized rats tested insulin sensitivity while 
sham LCR and HCR were used for basal tissue analysis. Plasma insulin levels did not 
differ during the clamps, but LCR required lower glucose infusion rates than HCR 
(p<0.05). Upon insulin stimulation, both absolute and normalized phospho-Akt(Ser
473
) of 
soleus muscle were significantly increased in HCR above basal group (p<0.05), but not in 
LCR. No difference was observed between insulin-stimulated phospho-Akt(Ser
473
) of 
HCR and LCR groups . These data support that LCR is linked to a reduction in insulin 
sensitivity in vivo without impairments of insulin-stimulated skeletal muscle phospho-
Akt(Ser
473
) vs HCR rats.  
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 1 
INTRODUCTION 
 
Diabetes, Obesity, and Physical Inactivity 
The mechanism linking diabetes, obesity, and physical inactivity is unknown; 
however, an integrated relationship appears to exist (Figure 1). Obesity increases the risk 
for diabetes, and insulin resistance has been shown to develop in those who are obese 
(Dwyer-Lindgren et al. 2013; Shulman 2000).  Physical inactivity has been linked to an 
increased risk of obesity as well. Sedentary behaviors demonstrate up to a 61% increase 
in the risk for developing obesity (Tremblay and Willms 2003). Physical inactivity has 
been demonstrated to reduce insulin sensitivity. After two weeks of reduced activity, the 
body becomes less insulin-sensitive (Krogh-Madsen et al. 2010).  
The centers for disease control and prevention (CDC) state that only 48% of 
adults met physical activity guidelines in 2008 (Centers for Disease Control 2014). This 
proportion is important, as the CDC links physical inactivity to an increase in risk factors 
for complex diseases (Centers for Disease Control 2011). 
There is a link between physical inactivity as it relates to the complex disease 
phenotype of diabetes (Figure 1) Physical inactivity is associated with increased insulin 
resistance, which is characteristic of type-II diabetes mellitus (TIIDM). Regions with 
lower proportions of physical inactivity and lower proportions of obesity tend to have a 
lower incidence of diabetes (Centers for Disease Control 2009). Taken together, there 
appears to be an association between physical inactivity, obesity, and the occurrence of 
diabetes. 
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Figure 1:  Geographical proportion of physical inactivity (A), obesity (B), and 
diabetes (C) within the Unites States in 2009. The darker shaded regions represent a 
higher percentage of the regional population who fit the description. Southern and 
Southeastern regions appear to have the darkest shading, indicating the highest 
incidences of all three phenomena.  This suggests a potential link between these 
observations (Centers for Disease Control 2009). 
 
A
) 
C
) 
B
) 
% Physically Inactive, 
Adults 
% Obese, Adults 
% Diabetes, Adults 
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Insulin Resistance as a Common Mechanism? 
Insulin resistance is a precursor to diabetes and has been shown to develop in 
obesity (Shulman 2000). Physical inactivity has also been linked to a reduction in 
peripheral insulin sensitivity, which leads to insulin resistance (Figure 2). Insulin 
resistance results in a reduction in glucose uptake into cells and is associated with TIIDM 
(Karp 2010; Campbell and Reece 2005). A reduction in insulin sensitivity is hallmark of 
insulin resistance. This causes a reduction in insulin signaling, altering the activation of 
several pathways within the cell (Karp 2010). Normal insulin signaling results in 
adequate glucose uptake for appropriate energy metabolism. These observations support 
an association of insulin resistance with diabetes, physical inactivity, and obesity, which 
may suggest insulin resistance is a common mechanism linking these phenomena. 
Insulin resistance is pronounced in skeletal muscle tissue (Wasserman and Ayala 
2005). Skeletal muscle tissue comprises much of body mass and is a major consumer of 
blood glucose. This is because skeletal muscle not only demands energy production for 
cellular processes, but also for force generation in mobility (Sasson et al. 1987). To fully 
understand the impact of insulin resistance, one must be familiar with the process of 
insulin-stimulated glucose uptake (Figure 3).  
 
Insulin Signaling and the Effects of Insulin Resistance 
Insulin is a peptide hormone generally associated with the regulation of blood 
glucose concentration. It is synthesized in β-cells within islets of Langerhans in the 
pancreas. After a meal, carbohydrates are degraded into simple sugars and absorbed into 
the bloodstream, therefore raising blood glucose levels. Due to the high glucose affinity  
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Figure 2:  Two weeks of reduced ambulatory activity reduces peripheral insulin 
signaling (Krogh-Madsen et al. 2010). In the x-axis of this figure, Ra refers to hepatic 
glucose production and Rd refers to glucose disappearance. The black bars indicate 
normal ambulatory activity whereas the white bars indicate post-intervention of two 
weeks reduction in ambulatory activity. In this figure, the y-axis refers to µmol/kg of 
glucose. These data demonstrate no difference in hepatic glucose production after two 
weeks of reduced ambulatory activity, p>0.05. However, there is a significant 
decrease in glucose disappearance rate after the reduction in ambulatory activity, 
*p=0.01. Figure and data taken from (Krogh-Madsen et al. 2010). 
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Figure 3:  Schematic illustration of insulin-stimulated GLUT4 translocation (Dash et 
al. 2009). Insulin binding leads to recruitment and activation of the insulin receptor 
substrate (IRS) and subsequent recruitment of phosphatidylinositol 3 kinase (PI3K). 
This recruitment catalyzes conversion of PIP2 to PIP3, which causes phosphorylation 
of Akt via PDK1and TORC2. Akt phosphorylates AS160 and suppresses GAP 
activity, which then leads to an increase in GTP-bound Rab proteins that facilitate 
GLUT4 vesicle translocation to the membrane. Figure taken from (Dash et al. 2009). 
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of GLUT2 within pancreatic β-cells, there will be a proportionate increase in glucose 
entry when blood glucose concentration rises. Glucose is converted into pyruvate and 
subsequently acetylated, increasing cytosolic adenosine triphosphate (ATP) 
concentration. The increased ATP concentration binds to and closes potassium ion 
channels. Reduced efflux causes slight depolarization that opens voltage-sensitive 
calcium ion channels. An increase in calcium concentration stimulates exocytosis of 
insulin-containing vesicles (Lodish et al. 2013).  
When insulin is circulated throughout the bloodstream, it binds to insulin 
receptors on cells, which results in an increase in glucose uptake. Insulin binds to specific 
tyrosine kinases at α-chains, causing receptor dimerization of extracellular domains via 
disulfide bonds. Subsequent cross-phosphorylation of intracellular β-chains stimulates 
cross-phosphorylation of intracellular tyrosine residues. Three tyrosine residues have 
been identified on β-chains being involved in an activation loop. Phosphorylation 
assumes a conformation apart from a newly-formed catalytic cleft and because of this 
conformational change, a specific rotation is required to bring catalytic residues closer 
together and open the cleft for binding substrates of intracellular proteins (Lodish et al. 
2013).  
Most substrates recruited to the insulin receptor within the cell have an SH2 
domain; however, the insulin-receptor substrate (IRS, which does not have an SH2 
domain) is also recruited. Autophosphorylation of IRS and SH2 domain-containing 
proteins creates docking sites for other SH2 domain-containing proteins and 
phosphotyrosine binding (PTB) domains. The initial recruitment of IRS-1 and IRS-2 
provides binding sites for several proteins and activates many pathways via 
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phosphorylation (Karp 2010). IRS proteins recruit phosphatidylinositol 3 kinase (PI3K), 
which converts PIP2 to PIP3 and causes phosphorylation of Akt. Akt phosphorylates 
AS160 and suppresses GAP activity, which then leads to an increase in GTP-bound Rab 
proteins that facilitate GLUT4 translocation to the membrane (Dash et al. 2009; White 
2003; Chang et al. 2004). 
Several transduction pathways are either directly or indirectly regulated by insulin 
stimulation. PKB-β (Akt2) has a primary role in insulin signaling, as its depletion causes 
a decrease in insulin responsiveness and glycogen synthase kinase-3 activity (GSK3) 
(Jiang et al. 2003). Further, insulin-signaling components are rapidly activated. Aerobic 
exercise increases glucose uptake and GSK3 activity, and hyperinsulinemia upregulates 
IRS-1 and PI3K activity (Worjtaszewski et al. 2000).  
In short, insulin promotes glucose uptake in healthy individuals, stimulating its 
conversion into a more efficient means of energy storage such as glycogen or lipids 
(Samuel and Shulman 2012). However, there exist several conditions in which insulin 
sensitivity is attenuated, altered, or dysfunctional altogether. TIIDM is a common 
example of this phenomenon, and is characterized by a reduction in the responsiveness of 
target cells, known as insulin resistance (Campbell and Reece 2005). An individual 
resistant to insulin has impaired transport of GLUT4 to the membrane (Karp 2010).  
TIIDM can occur when the insulin receptor becomes resistant to insulin, which 
can cause defects in insulin signaling pathways. Insulin resistance is a common, yet 
complex disorder of the endocrine system that is characterized by defective receptor 
signaling or overstimulation of receptors, yielding hyperglycemia (Bornfeldt and Tabas 
2011). Risk factors for insulin resistance are dynamic, but these factors are frequently 
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associated with obesity and sedentary lifestyle (Karp 2010). As the occurrence of obesity 
and sedentary lifestyle remains high, insulin resistance manifested as TIIDM has become 
a public health concern. By the year 2020, it is estimated that there will be 250 million 
cases worldwide, and by the year 2050, it is estimated that one in three Americans will 
have TIIDM (Shulman 2000; Samuel and Shulman 2012). Insulin resistance is commonly 
present 10-20 years before an official diagnosis of TIIDM, meaning there is impairment 
in insulin signaling and glucose uptake many years before any treatment plan is started. 
Physical activity decreases the risk for diabetes. It has long been known that 
aerobic exercise training improves insulin sensitivity (Medeiros et al. 2010; 
Wojteszewski et al. 2000). Along with alterations in diet, aerobic exercise might be one 
of the best natural remedies against insulin resistance; and while genetic predispositions 
to diabetes might exist, lifestyle modifications greatly reduce these risks.  
Profiles during a hyperinsulinemic clamp showed gene expression in skeletal 
muscle with 284 genes down-regulated and 478 genes up-regulated (Figure 4). Further, 
29% of genes affected were involved in translational or transcriptional regulation, 
indicating a major role of insulin in regulation of protein expression (Rome et al. 2003).  
Fourteen percent of transcriptional genes responsive to insulin were involved in 
energy metabolism, and 12% of the genes were involved in intercellular signaling (Rome 
et al. 2003). There are dynamic and complex roles for insulin in many signaling 
pathways. An individual resistant to insulin may exhibit altered transcriptional and 
translational regulation. Insulin resistance may alter gene expression involved in 
translation, transcription, and energy metabolism. Deconditioning, which is defined as 
neglecting physical activity, leads to a reduction in gene expression for insulin and 
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Figure 4:  Distribution of fold change in mRNA levels induced by insulin in human 
skeletal muscle (Rome et al. 2003). This figure shows almost 250 genes having a 2-3 
fold increase in expression upon insulin stimulation. In addition, there appears to be 
almost 140 genes with a -1.5 to -2 fold decrease in expression upon the same insulin 
stimulation. Insulin has a dynamic impact on gene expression and appears to modify 
the expression of 762 genes. 
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adipocytokine signaling. Gene expression for these categories were up-regulated in 
physically conditioned muscle, suggesting that physical activity plays a role in the 
diabetes (Lammers et al. 2012).   
 
Muscle Glucose Uptake 
Skeletal muscle glucose uptake is dynamic, but often it is distinguished by three 
phases:  an extracellular component, and transport component, and an intracellular 
component (Figure 5). The interaction of these physiological mechanisms regulate 
glucose uptake into skeletal muscle (Wasserman and Ayala 2005).  
The extracellular component relates increased blood flow to an increase in 
substrate delivery to the cell. In mice treated with sildenafil + L-arginine, which acts as a 
vasodilator, glucose uptake was significantly greater in soleus and gastrocnemius muscle 
tissues as compare to mice treated with a control vehicle (Ayala et al. 2007). This 
suggests an important role in glucose delivery to muscle tissue in the bloodstream.  
The transport component of glucose uptake indicates the importance of GLUT4 
translocation to the membrane for adequate glucose uptake. GLUT4 knockout mice were  
observed to have significantly less insulin-stimulated glucose uptake than control mice 
(Stanford and Goodyear 2014). Further, there appears to be an exercise component 
regulating GLUT4 translocation for glucose uptake. During an acute bout of exercise, 
mice lacking the insulin receptor were observed to have similar glucose uptake to mice 
with intact insulin receptors (Stanford and Goodyear 2014). Individuals with TIIDM 
experience a reduction in blood glucose concentrations during acute bouts of exercise 
because of exercise-induced glucose uptake (Rose and Richter 2005). Together, these 
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Figure 5:  Interaction of physiological mechanisms in control of muscle glucose 
uptake (Wasserman and Ayala 2005). The first component involves substrate delivery 
to the cell, known as the extracellular component. The second component involves 
glucose transport from extracellular spaces into the cell, known as the membrane 
component. The final component involves hexokinase phosphorylation of glucose to 
maintain its presence in the cell, known as the intracellular component. Any of these 
steps can be rate-limiting in glucose metabolism. 
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data support the need for GLUT4 in facilitating glucose transport across the cell 
membrane. 
Finally, the intracellular component indicates the need for glucose to be 
phosphorylated by hexokinase-II, an enzyme initiating the first step in glycolysis. 
Glycolysis then catabolizes glucose into useable products for energy production (Rose 
and Richter 2005).  
Any component in skeletal muscle glucose uptake may be rate-limiting; however, 
investigators generally agree that transport activity of glucose across the membrane is the 
most common rate-limiting step (Figure 6). The transport of glucose depends on GLUT4 
translocation through insulin-stimulation or exercise-mediated mechanisms (Stanford and 
Goodyear 2014). Insulin resistance is observed in skeletal muscle tissue as a reduction in 
glucose uptake into the cell, further supporting that transport activity is a common rate-
limiting step (Rose and Richter 2005). 
 
Modern Exercise Physiology in Medicine:  New Models for Discovery 
Exercise has long been known to have several health benefits. As part of a health 
treatment plan, exercise is associated with positive health outcomes and sedentary 
behavior is associated with a reduction in positive health outcomes (Bamman et al. 2014; 
Thyfault and Krogh-Madsen 2011). Further, aerobic exercise is associated with an 
increase in or maintenance of working levels of aerobic capacity (Gaesser and Rich 1984; 
Pollock et al. 1987). In addition, exercise is linked to improved insulin sensitivity and has 
been shown to reverse impairments in glucose uptake observed in TIIDM (Lessard et al. 
2011; Medeiros et al. 2010). Sedentary behavior is linked to an increased risk of  
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Figure 6:  Molecular mechanisms regulating glucose uptake in skeletal muscle 
(Stanford and Goodyear 2014). Scientific investigators suggest glucose membrane 
transport is rate-limiting in insulin resistance. GLUT4 translocation to the membrane 
is needed for glucose uptake into the cell. On the left, the figure shows insulin binding 
to its receptor and recruiting IRS-1, which then recruits PI3K. This recruitment allows 
phosphorylation of Akt, which is required for insulin-stimulated GLUT4 translocation. 
On the right, the figure shows plausible means of exercise-stimulated glucose uptake 
via GLUT4 translocation to the membrane. Stanford and Goodyear postulate Ca
2+
 and 
calmodulin are primarily responsible for exercise-stimulated glucose uptake. Studies 
support a lack of skeletal muscle glucose uptake in GLUT4 knockouts. 
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developing TIIDM (Hamilton et al. 2014). From these data, exercise appears to increase 
the likelihood of good health while decreasing the risks for poor health. But to fully 
understand the impact of exercise on health and to what extent it aids in cellular 
physiology, it may be helpful to review some history in exercise physiology. 
Exercise physiology has been applied for years, but the discovery of heat 
production in muscle in 1920 is where modern exercise physiology really established its 
roots. In this experiment, heat production was characters at different phases of muscle 
contraction, relaxation, and recovery (Hill and Hartree 1920). Much of the heat 
production was anaerobic, which then began investigation on what is now known as 
aerobic and anaerobic metabolism (Hartree and Hill 1923). 
A.V. Hill was a long-distance runner and noticed what appeared to be a maximum 
level of oxygen consumed by himself and other athletes during bouts of exercise (Hill et 
al. 1924). From these observations came the term ―VO2 max,‖ which was later described 
as the maximum amount of oxygen taken up by the body at peak levels of physical 
exertion. At this level, any increase in physical exertion does not elicit an increase in 
oxygen consumption (Hill et al. 1924). 
In 1977, data were published suggesting mitochondrial adaptations in response to 
exercise (Figure 7). In this study, athletes were trained for eight weeks at 45% of VO2 
max with muscle biopsies taken each week. After three weeks of training, both oxidative 
and glycolytic enzymatic activity increased in addition to working aerobic capacity. 
These adaptations were reversed after two weeks of detraining (Henriksson and Reitman, 
1977). These data support exercise benefits at the cellular level and suggest a reversal of 
these benefits is associated with physical inactivity.  
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Figure 7:  Time course for changes in two mitochondrial enzymes and VO2 max 
during training and detraining (Henriksson and Reitman 1977). The left panel shows 
the effect of training on enzymatic activity. After three weeks of training, there begins 
to be an increase in oxygen uptake, succinate dehydrogenase (SDH) activity, and 
cytochrome c oxidase activity. At the conclusion of 8 weeks, there are significant 
increases in all three measures. The right panel shows the effect of detraining or 
physical inactivity on enzymatic activity. After six weeks of detraining, there are 
significantly lower levels of SDH activity and cytochrome c oxidase activity. 
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Aerobic capacity refers to a working percentage of VO2 max and is implicated by 
a component of time. Thus, exercise training might increase the duration of a high 
working percentage of VO2 max due to skeletal muscle mitochondrial adaptations and 
increased cardiorespiratory fitness (Bruce 1984). Studies consistently link high aerobic 
capacities with increased longevity and increased overall health; however, it has not been 
easy to test the effect of aerobic capacity on different health outcomes due to many 
external factors, such as training (Koch et al. 2012). In 2005, a study was published on 
two lines of rats contrasting for aerobic capacities based on an endurance run to 
exhaustion (Figure 8). From an NIH stock of rats, these rats were run on a treadmill at 
15% and 6 m/min until exhaustion. Rats running furthest were selected to breed together, 
beginning the high endurance running capacity (HCR) group to mimic high aerobic 
capacity. Rats running the least were selected to breed together, beginning the low 
enduring running capacity (LCR) group to mimic low aerobic capacity (Wisloff et al. 
2005). 
This rat model has been used in many countries and provides an unbiased model 
to assess the impact of aerobic capacity on different health outcomes (Koch and Britton 
2005). As mentioned before, high aerobic capacity is consistently linked with positive 
health outcomes and increased longevity in an unbiased rat model (Figure 9). Further, 
VO2 max has been used consistently as a measure of cardiorespiratory function and 
potential, which regulates oxygen delivery for cellular energy production (Timson et al. 
2008). 
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Figure 8:  Generation 0-11 of rats selected for low and high intrinsic endurance 
running capacity (Wisloff et al. 2005). After six generations, a significant difference 
was observed in endurance running capacity and after 11 generations, the difference in 
endurance running capacity was 347%. Endurance running capacity is an indirect 
measure of functional aerobic capacity. 
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Figure 9:  A prospective test of the ―aerobic hypothesis‖ in rats selectively bred to 
contrast for intrinsic endurance exercise capacity (Koch et al. 2011). This figure 
highlights lifespan of LCR and HCR rats at generation 14. The median life expectancy 
of LCR rats was 24.0 months whereas HCR rats had a median of 34.7 months 
(p<0.001). 
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Aerobic Capacity in LCR and HCR Rats 
VO2 max is a measure of the maximum amount of oxygen taken up by the body at 
peak levels of physical exertion. At this level, any increase in physical exertion maintains 
the same oxygen consumption in the body. Oxygen is essential for aerobic organisms as 
its utilization is required for adenosine triphosphate (ATP) production during oxidative 
phosphorylation. Oxygen is reduced in the electron transport chain and therefore able to 
accept electrons via redox reactions in mitochondrial membranes. This transfer of 
electrons through different complexes helps to generate energy for the inner 
mitochondrial membrane to pump protons across its membrane and subsequently 
generate potential energy via a pH gradient. As protons flow back across the gradient to 
reestablish proton concentration equilibrium, there is production of ATP as these protons 
cycle through ATP synthase (sometimes called Complex V). This coupled process of 
chemiosmosis provides considerable amounts of energy production for cellular functions 
(Lodish et al. 2013). Therefore, oxygen metabolism and energy transfer govern intrinsic 
aerobic capacity.   
As organisms evolved, the presence of oxygen within cells has increased energy 
transfer 18-fold (Koch and Britton 2005). This improvement in energy transfer may have 
facilitated increased survival and lifespan. Data support many diseases are a direct result 
of defective mitochondria or impairments in mitochondrial oxidation/detoxification 
pathways (Koch and Britton 2005). A high aerobic capacity is consistently linked with 
increased longevity in unbiased rat models. The increased ability to consume and utilize 
oxygen is directly related to survival in this model, as low aerobic capacity has  
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demonstrated increased risks for conditions related to early morbidity. Known as the 
―aerobic hypothesis,‖ a large reduction in the energy transfer of oxygen is central to 
complex disease phenotype and aging in rats (Koch et al. 2011).  
Whereas intrinsic aerobic capacity is primarily regarded as a genetic trait, there 
are environmental interventions to increase aerobic capacity and subsequently increase 
physical fitness levels (Koch and Britton 2005).  Exercise is the intentional maintenance 
of some component of physical fitness (Caspersen et al. 1985). Many US individuals take 
no measures in maintaining or increasing components of fitness (Physical Activity, 
Figure 1). 
Low aerobic exercise capacity has potential to increase the risk of certain 
mortality-related diseases, an theory known as the ―aerobic hypothesis‖ (Koch et al. 
2011). With these observations, low aerobic capacity may be associated with a reduction 
in insulin sensitivity. Hoydal and colleagues state that within an established line of 
artificially selected high and low-aerobically conditioned rats, the rats of low aerobic 
capacity portrayed greater insulin resistance (Hoydal et al. 2014). 
Aerobic exercise is associated with increases in functional aerobic capacity (Short 
et al. 2003). Insulin signaling and glucose transport ex vivo is lower in rats artificially 
bred for low-aerobic capacity as compared with high-aerobic capacity rats. In skeletal 
muscle, aerobic exercise training increases aerobic capacity and reverses many 
impairments to glucose metabolism (Lessard et al. 2011). While a correlation between 
physical activity and insulin signaling may exist, it remains unclear whether physical 
activity and aerobic capacity regulate insulin signaling in vivo. 
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AKT (Protein Kinase B) of the Insulin Signaling Pathway 
Phosphorylation of protein kinase B (PKB or Akt) is a common measure of 
functional insulin signaling (Manning and Cantley 2007). Insulin-mediated activation of 
Akt gives stimulates translocation of the GLUT4 vesicle to the plasma membrane for 
glucose uptake (Gonzales and McGraw 2009). Akt has been demonstrated to be required 
for appropriate GLUT4 translocation to the membrane and to maintain glucose 
homeostasis. Further, insulin signaling is often measured indirectly as a function of 
protein kinase activation by probing for phosphorylated Akt (Ser
473
) and its associated 
substrates (Lessard et al. 2011).  
Akt is a versatile protein kinase and an important signaling node in higher 
eukaryotic cells. Its abundance throughout all cell types renders its central role in 
regulation of human physiology and complex disease.  (Manning and Cantley 2007). Akt 
exists in three isoforms (Akt1, Akt2, and Akt3), each with unique functions and likely 
subcellular specificity. Akt1 is the most prevalent isoform in endothelial cells and 
functions in angiogenesis and cell growth. This is made evident as Akt1 knockout mice 
do not grow to be as large as wilder-type counterparts, which is possibly due to the ability 
of Akt to activate endothelial nitric oxide synthase via phosphorylation of S1177, 
therefore increasing vascular remodeling and vasodilation consistent with angiogenesis 
and growth (Manning and Cantley 2007; Gonzalez and McGraw 2009).  
Akt2 is the most prevalent isoform in tissues that are sensitive to insulin. Its 
activation stimulates GLUT4 translocation to the plasma membrane (Manning and 
Cantley 2007). Akt2 knockout mice manifest impairments in glucose utilization similar to 
that of Type-II diabetes mellitus (Gonzales and McGraw 2009). Hypotheses have been 
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made suggesting that insulin will preferentially accumulate Akt2 in insulin-sensitive 
tissues, over other Akt isoforms, to the plasma membrane. Although this might be true, 
the mechanism for this observation is not clear (Gonzalez and McGraw 2009).  
Finally, Akt3 is thought to function in neuronal development as Akt3 knockout 
mice show impairments in early brain development (Gonzalez and McGraw 2009). 
Recent data suggest a link between insulin resistance and cognitive impairment (Biessels 
and Kappelle 2005; Liu et al. 2011; Ferreira et al. 2014). Insulin is known to play some 
kind of role in learning, memory, and neuromodulatory functions (De Felice et al. 2014).  
In summary, there exists an unidentified mechanism linking diabetes, obesity, and 
physical inactivity. A common phenomenon observed in each condition is reduced 
insulin sensitivity (Dwyer-Lindgren et al. 2013; Shulman 2000; Tremblay and Wilms 
2003). Physical inactivity is associated with reductions in insulin sensitivity, and 
sedentary behavior has been consistently linked to poor health outcomes. Conversely, 
physical activity has demonstrated reversal in metabolic impairments and has been 
consistently linked to positive health outcomes (Medeiros et al. 2010; Lessard et al. 2011; 
Koch et al. 2009). Appropriate insulin signaling is crucial to maintain energy metabolism 
(Campbell and Reece 2005). Exercise is an intentional form of physical activity with the 
intention of improving physical fitness, and exercise may result in skeletal muscle 
metabolic adaptations which are reversed due to physical inactivity (Caspersen et al. 
1985; Henriksson and Reitmann 1977). These adaptations may help increase functional 
levels of aerobic capacity (Henriksson and Reitmann 1977). High aerobic capacity is 
associated with increased health and longevity in rat models, with data suggesting insulin 
resistance in LCR rats ex vivo as compared to HCR rats (Koch et al. 2009; Lessard et al. 
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2011). Together, these data and observations may support a link between low aerobic 
capacity and reductions in insulin sensitivity which manifest through insulin signaling 
protein expression. 
 
Hypotheses 
My hypotheses were as follows:  1) Low aerobic capacity is associated with 
reduced whole-body insulin sensitivity in a conscious, unrestrained rat and 2) Low 
aerobic capacity is associated with reductions in Akt signaling in slow, oxidative skeletal 
muscle (soleus). 
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MATERIALS AND METHODS 
 
Research Compliance  
All research compliance training and certification was obtained via CITI modules 
in October, 2013.  This project followed guidelines set forth by both an Institutional 
Review Board and a Situational Animal Care and Use Committee in the spring of 2014. 
Animals used in this study were treated according to an approved protocol such that 
appropriate care and oversight was ensured. 
 
Obtaining and Preparing Rat Cohorts 
Aerobic capacity is a predictor of mortality and strongly associated with longevity 
(Koch et al. 2012). Further, aerobic exercise has been shown to reduce insulin resistance 
(Medeiros et al. 2010). Together, these observations imply that aerobic capacity might 
play a role in insulin resistance and might be associated with a type-II diabetes mellitus 
phenotype.  
The selection process began with a founder population of heterogeneous N:NIH 
rats (n=168). Through an inclined run to exhaustion, investigators ascertained intrinsic 
aerobic capacity since a relationship exists between running velocity and oxygen 
consumption (Koch and Britton 2001). Rats running farthest were selected to breed 
together to begin the high aerobic capacity line; rats running the least amount were 
selected to breed together to begin the low aerobic capacity line. To maintain genetic 
variation, a rotating cycle of 13 rat families was scheduled to keep the rate of inbreeding 
less than 1%, which also helped reduce environmental variance (Koch and Britton 2005). 
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Divergent lines became significantly apparent within 6 generations (Koch and Britton 
2001). After 11 generations, there was observed to be a 347% difference in running 
capacity, suggesting there may be a difference in intrinsic aerobic capacity (Wisloff et al. 
2005). Using this rat model, both genetic and environmental influences affecting aerobic 
capacity and cellular physiology can be examined (Koch et al. 2012).  
To test the hypotheses listed above, LCR and HCR rat cohorts following 34 
generations of selective breeding were obtained from the University of Michigan. HCR 
rats ran further than LCR rats, suggesting an intrinsic difference in aerobic capacity, 
p<0.001  (Figure 10). Fourteen HCR rats and fourteen LCR rats were used in this study 
beginning in April, 2014. Rats were housed singly, maintained on a 12-hour light/dark 
schedule, and acclimated for least two weeks upon arrival. 
 
Body Mass and Food Consumption 
Body mass measurements and food consumption measurements were made once 
per week throughout the duration of survival studies. Rats were massed in a tared 
container on an electronic triple beam balance. Food mass for each week was measured 
in a tared container on an electronic triple beam balance. Data were plotted in excel 
spreadsheets and graphs were made to observe change in mass over time. In addition, 
transformed data were obtained by dividing the mass of food consumed each week by the 
average body mass for each week. Data included in this project reflects results after 12 
weeks of data collection. After 12 weeks, LCR and HCR rats were sub-divided to one of 
four groups for in vivo data collection.  
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Figure 10:  Running distance to exhaustion of HCR and LCR rats obtained from 
University of Michigan after 34 generations. Endurance running capacity is a good 
indication of intrinsic aerobic capacity. The HCR rats on average ran 10X further than 
LCR rats (p<10
-17
). The difference in intrinsic aerobic capacity manifests with this initial 
treadmill running test to exhaustion, ***p<0.001. 
  
*** 
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Group Assignments 
To determine the impact of aerobic capacity on insulin sensitivity and insulin 
signaling, LCR and HCR rats were divided and weight-matched into one of two groups:  
basal (B) or insulin-stimulated (IS).  Rats in the IS group were catheterized and clamped, 
as described below. Rats in the B group underwent a similar, sham surgery. The final 
groups were as follows:  LCR-B (n=7), LCR-IS (n=7), HCR-B(n=7), and HCR-IS (n=7). 
Since surgery survival was not 100%, the final groups used in the analysis were as 
follows:  LCR-B (n=4), LCR-IS (n=3), HCR-B (n=7), and HCR-IS (n=5). Groups were 
assigned based on body mass at week 12 so there was no difference between groups 
within LCR and HCR cohorts.  
 
Mouse Antenna for Sampling Access (MASA) Production 
The MASA is a device constructed to isolate and secure intravenous catheters on 
the back of a rat necks for placement, sampling, and ease of access to catheter tubing. 
MASA construction included silicone medical adhesive, Tygon 0.02‖x0.06‖x0.02‖ 
tubing (Fisher Scientific), 0.132‖x0.183‖ tubing (Fisher Scientific), and 22G blunt 
hypodermic tubing. Twenty-two gauge blunted needles were used for connecting the 
MASA to the catheters.  
First, 1 ½ 22G needles were blunted on two sides using a file and pliers to a 
needle length of 24.0 mm. Then, two pieces of 0.02‖x0.06‖x0.02‖ tubing were cut to 
lengths of 50.0 mm. One piece of tubing was colored red and designated for the arterial 
line while the other tubing was colored black and designated for the venous line. These 
tubes were each connected to blunted, 22G needles. After tubing was connected to 
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blunted needles, the needles were bent to a 135
o
 angle and positioned 45
o
 from each other 
. A 22.0 mm piece of 0.132‖x0.183‖ tubing was cut and placed over the two smaller 
tubes so the red tubing was on the left when the needles were pointing away (This would 
ensure the red tubing was always assigned to the left carotid artery per surgery protocol). 
Finally, silicone adhesive was placed on a plastic weigh boat and the MASA was placed 
in the adhesive and adjusted for desired formation. All MASAs were autoclaved and 
prefilled with 10 mU/mL heparinized saline prior to use in surgery. Final angle 
measurements, lengths, and placement varied as each MASA was customized to fit each 
rat in surgery.  
 
Carotid and Jugular Catheterization  
Under guidance from Missouri State University’s veterinarian and IACUC panel, 
surgery protocol was approved and practiced on Sprague-Dawley rats before beginning 
LCR and HCR surgeries. LCR-IS (n=7) and HCR-IS (n=7) underwent a catheterization 
procedure as described by Ayala et. al (2011) to include the left carotid artery and the 
right jugular vein. The surgery required the following sterile instruments:  10 cm straight, 
serrated, extra fine Graefe forceps (FST by Dumont), 10 cm curved, serrated, Graefe 
forceps (FST by Dumon), 3 mm straight Vannas spring scissors (LaCrosse Stainless), 10 
cm sharp Iris scissors (LaCrosse Stainless), 12.5 cm Halsey micro needle holder, 12.5 cm 
straight and smooth ultra-fine Hemostat (FST by Dumont), serrated Adson forceps (FST 
by Dumont), and 2 teeth curved Iris forceps. The body mass of each rat was taken prior to 
surgery preparation so antibiotic injection could be calculated. The surgical table was 
sterilized with 70% bleach followed by 70% isopropanol, and bench guards were taped 
 29 
down prior to surgery. A heating pad was set on low and a sterile, surgical drape was 
taped over the heating pad. Finally, the anesthesia nose-cone was placed on one end of 
the surgical field and taped down. A surgical tray was sanitized with 70% ethanol, as 
were all surgical instruments prior to surgery. The tray was then filled with 1 part 
cyclohexamide to 200 parts cool water with all surgical instruments placed inside the 
surgical tray until needed.  
Rats were placed in chamber pre-filled with 3-4% isoflurane anesthetic gas. Upon 
anesthetization, rats were transferred to the surgical field with the nose placed in the 
nose-cone for continuous oxygen/anesthesia administration throughout surgery. The rat 
was prepared for surgery by shaving the neck from the chin to the xiphoid process, and 
outward to the shoulder. Claws were clipped and puralube ophthalmic ointment (Dechra) 
was applied. The rat was flipped and shaved from the base of the skull to the 
shoulderblades, and outward to the sides of the neck. After the rat was prepared for 
surgery, the rat was raised off the surgical drape and a new, sterile drape was placed 
between the rat and the heating pad. Preparation continued with application of betadine 
solution to recently shaved areas. Extremities were taped down before placing a sterile 
drape over the rat. 
A small, midline incision was made from the hyoid to the middle of the base of 
the sternum. Tissue was blunt-dissected to expose the sternomastoid muscle on the left 
side of the rat. The muscle was reflected to expose the left carotid artery and extra tissue 
was teased off the artery. Before isolation of the artery, it was important to isolate the 
vagus nerve away from the artery. After the artery was isolated with forceps, the artery 
was tied off with silk suture (Fine Science) at the cephalic end and a loose knot was tied 
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at the caudal end. A small incision was made in the artery for insertion of a sterile, 
beveled catheter which was prefilled with 10 mU/mL heparinized saline. This catheter 
was tied securely to the artery and patency was tested using a syringe and blunted needle 
for catheter access before clamping the catheter with a sterile pin. 
On the right side of the rat, tissue was teased until the jugular vein was isolated. 
The vein was tied at cephalic and caudal ends as previously described and a small 
incision was made. A sterile, beveled catheter was prefilled with 10 mU/mL heparinized 
saline before placement into the jugular vein. The catheter was tied securely before 
testing patency with a syringe and blunted needle attached to the catheter. After patency 
was ensured, the catheter was clamped with a sterile pin. 
When both lines were patent, the rat was flipped dorsally to expose the back. A 
small incision was made between shoulder blades extending from the base of the skull. A 
blunted needle was tunneled from the ventral incision around both sides of the neck to the 
interscapular incision made on the back. The catheters were threaded through the blunted 
needle such that the catheter placement in the front of the body resulted in catheters being 
run out the dorsal incision. 
The MASA was placed in the interscapular incision. Blunted needles extending 
from the MASA were custom-bent to fit the incision and meet the catheters. The carotid 
line in the MASA was clamped, cut to desired length, and attached to the MASA. The 
jugular line in the MASA was clamped, cut to desired length, and attached to the MASA. 
Patency was confirmed after unclamping the MASA by using syringes and blunted 
needles to draw up blood. A lock solution of 50 mU/mL heparinized saline in 10% 
glycerol was inserted in the MASA lines to reach into the catheters.  
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Antibiotic and pain-relieving injections were administered. Medications consisted 
of Metacam (0.15 mg/kg), Baytril antibiotic (10 mg/kg), and 3.0 mL saline subcutaneous 
injections.  
Incisions were closed with nylon suture and 2% mupirocin ointment (Dechra) or 
Neosporin (Johnson & Johnson) was applied to the incision. Lidocaine ointment (Taro 
Pharmaceuticals) was applied on and around the sites of incision for pain relief. The rat 
was given oxygen for a short time until observed to slightly regain consciousness, when 
the rat was transferred to a clean cage for recovery. The cage was half-placed on a 
heating pad for 24 hours to aid in the recovery process, with food and water available at 
all times. Each day the body weight was monitored in addition to overall wellbeing. Rats 
were deemed unsuccessful in surgery if the body mass dropped more than 20% from pre-
operative body mass or if overall appearance did not seem healthy (such as staggered 
breathing or foaming at mouth).  
Daily post-operative care included testing catheter patency and flushing catheters 
with heparinized saline solution. Observations and care included measuring body mass, 
applying antibiotic ointment, and making notes about the overall health and appearance 
of the rat. Rats were allowed to recover at least 5 days and no more than 7 days before 
performing a metabolic clamp procedure (as described below). Other materials used but 
not previously mentioned are trimmers, sterile boxes, gauze, cotton swabs, sterile saline 
solutions, and other sterilized surgical instruments as needed. 
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Euglycemic-Hyperinsulinemic Clamp 
A euglycemic-hyperinsulinemic clamp was performed to measure insulin 
sensitivity (Ayala et al. 2011). This procedure involved a steady infusion of insulin while 
altering glucose administration until a target value of blood glucose concentration was 
obtained (Figure 11). Literature suggests a clamped value of blood glucose concentration 
to be 130 mg/dL. This procedure allowed for accurate measurement of blood glucose 
concentration and determination of insulin sensitivity (Tam et al. 2012). This clamp 
procedure provided a good way to measure insulin sensitivity and therefore define an 
insulin-resistant phenotype commonly manifested in TIIDM. 
Rats fasted 5 hours prior to the clamp procedure, where t=0 min refers to the time 
immediately following the conclusion of the fast. Rats in B groups began fasting 1 hour 
prior to rats in IS groups. This allowed for time to euthanize a rat from the B group and 
harvest tissues in the same day before beginning the clamp procedure for an IS rat. All 
rats were massed prior to fasting so calculated values of 0.25 mU/µL insulin 
administration could be made to infuse at 4 mU/kg/min. Insulin was made using 50.0 µL 
of 100 U/mL insulin (Novolin) placed into 20.0 mL 3.0% albuminized saline (600.0 µL 
plasma in 19.4 mL saline). Glucose was purchased as a 50% dextrose solution. The 
arterial line used for blood sampling was prefilled with 10 U/mL heparinized saline, 
while the glucose and insulin lines were prefilled with respective solutions. The glucose 
and insulin lines were connected via a y-connector to provide steady infusions of each 
into the jugular line.  
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Figure 11:  Experimental design for the euglycemic-hyperinsulinemic clamp procedure. 
Panel A) shows the time layout from the beginning of the fast (t=-300 min.) to the 
infusion of glucose and insulin (t=120 min.). Insulin was infused constantly at 4 
mU/kg/min whereas glucose was infused at variable rates so as to plateau blood glucose 
concentration at 130 mg/dL. The red blood droplets indicate blood glucose readings that 
were taken every 10 minutes during the metabolic clamp procedure. Panel B) displays the 
setup of insulin and glucose infusion pumps into the jugular vein of a catheterized rat and 
blood sampling access from the carotid artery. 
 
 
 
 
A) 
B) 
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IS rats were connected to the arterial sampling line and jugular infusion line two 
hours prior to the start of the clamp procedure to acclimate to the setup so the procedure 
accurately reflected results of insulin sensitivity in a conscious, unrestrained rat.  
The first blood sample was taken at t=-10 min for a baseline reading to ensure the 
rat was not hypoglycemic and also to set an initial glucose infusion rate. A small sample 
of blood was taken in a capillary tube for hematocrit reading. Insulin was administered 
via the infusion pump just seconds before glucose so activation of signaling pathways 
would prevent hyperglycemia. Blood glucose readings were taken at t=0 min and then in 
10 minute intervals for the duration of the 2-hour clamp procedure. Fresh arterial blood 
was drawn from the carotid artery and read on a ReliOn Prime glucose meter with ReliOn 
Prime blood glucose test strips (Walmart). Blood glucose measurements, along with 
glucose infusion rates, were recorded throughout the duration of the clamp procedure 
until the target blood glucose range of about 130 mg/dL was obtained for consecutive 
readings. After each blood glucose readings, the glucose infusion rate was adjusted in 
accordance with the reading in attempt to obtain the target reading of 130 mg/dL. At the 
conclusion of the study, a small sample of arterial blood was taken for hematocrit reading 
to ensure minimal loss of blood during the study. About 1.0 mL of blood was taken from 
the arterial line for plasma insulin concentration at t=120 min. All blood samples were 
taken with heparin-coated syringes and the blood was placed into prelabeled EDTA-
coated tubes.  
Blood samples were centrifuged for 4 min at 4.0 
o
C and plasma supernatant was 
transferred to 1.5 mL prelabeled microcentrifuge tubes and stored in a freezer at -80.0 
o
C 
until Magpix (Merck) analysis. 
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After blood samples were taken, rats were anesthetized in a chamber prefilled 
with 3-4% isoflurane gas so that tissues could be harvesting. 
 
Tissue Harvesting 
Immediately following the clamp procedure, insulin-stimulated blood samples 
were taken from the carotid arterial line of IS rats. IS rats were immediately placed under 
3-4% isoflurane gas anesthesia before tissue collection. Rats in B groups were taken from 
the cage at the conclusion of the 5-hour fast and placed in a chamber prefilled with 3-4% 
isoflurane gas for anesthetization. Both tissue and blood collection was performed under 
anesthesia for rats in B groups. Blood samples were taken from B groups via a heart stick 
prior to tissue collection. Capillary tubes were used to determine hematocrit levels of IS 
rats both before and after the clamp procedure and analyzed by centrifuging samples and 
reading on a hematocrit reader. 
The surgical table was sanitized and a benchguard taped down before transferring 
the rat from the isoflurane chamber to the nose-cone administration of gaseous 
anesthesia. All instruments were sterilized with 70% ethanol along with the surgical tray. 
The tray was filled with 1 part cyclohexamide to 200 parts cool water and the instruments 
were placed in the surgical tray for the entirety of tissue harvesting procedures. This 
ensured sterility as tissues were being harvested.  
The gastrocnemius, soleus, plantaris, liver, heart, epididymal fat, mesenteric fat, 
and brain samples were harvested (Morris) for protein analysis using a 10.0 cm straight, 
serrated, an extra fine Graefe forceps, and a 10.0 cm sharp Iris scissors. Samples were 
rinsed in ice-chilled PBS and were dabbed on sterile gauze before being wrapped in 
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prelabeled aluminum foil and immediately flash-frozen in liquid nitrogen. Samples were 
transferred to Missouri State University where the samples were stored at -80.0 
o
C for 
future analysis. Brain samples were dissected by Margaret Thornton and Katelyn Moore. 
 
Tissue Homogenization 
Forty soleus muscle samples from basal and insulin-stimulated LCR and HCR 
rats were taken from -80 
o
C storage and placed into liquid nitrogen. Muscle mass was 
recorded in milligrams using an electronic triple beam balance (Mettler Toledo). Samples 
were again placed in liquid nitrogen following mass measurement. Two 1.50 mL 
microcentrifuge tubes were labeled for each soleus muscle homogenate and chilled on 
ice. The Tris-Triton buffer used in the working lysis buffer was comprised of the 
following materials:  10 mM Tris (pH=7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
1% Triton x-100, 10% glycerol, 0.10% SDS, and 0.50% deoxycholete. The working lysis 
buffer was prepared using 99 µL of the Tris-Triton buffer and 1 µL proteinase inhibitor 
cocktail (Sigma P8340) per 10 mg of muscle sample. This lysis buffer of 100 µL 
buffer/10 mg muscle was transferred into a prechilled 10.0 mL glass tube, using a 1000 
mL pipet, for muscle tissue homogenization. Muscle tissues were transferred from liquid 
nitrogen one sample at a time into a mortar that was prechilled in liquid nitrogen. The 
muscle sample was then crushed using a prechilled pestal until the tissue resembled a 
powder. The muscle powder was then transferred to the prechilled 10.0 mL glass tube 
where the sample was lysed using a probe to grind tissue and mix with the lysis buffer. 
Upon completion of muscle tissue lysis, the homogenate was transferred to 1.50 mL 
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prechilled and prelabeled microcentrifuge tubes using a 1000 mL pipet with a widened 
tip for efficient transfer. 
When all muscle homogenate had been collected, samples were centrifuged at 4 
o
C for 15 minutes and the supernatant was transferred to 1.50 mL prelabeled and 
prechilled microcentrifuge tubes. Exactly 10.0 µL of each supernatant was transferred to 
a 500 µL prelabeled, prechilled microcentrifuge tube for use in a BCA assay that would 
determine protein content. The remaining soluble muscle homogenate was stored at -80.0 
o
C until further analysis. 
 
Bicinchoninic assay (BCA) 
A BCA protein assay was performed to determine protein concentration (Figure 
12). A stock solution of BSA was prepared by measuring 48 mg albumin (Abcam) on an 
electronic triple beam balance and mixing with 10.0 mL phosphate buffered saline (PBS). 
Ten standards were prepared to suit the following concentrations:  600 µg/mL, 300 
µg/mL, 150 µg/mL, 75 µg/mL, 37.5 µg/mL, 18.75 µg/mL, 9.375 µg/mL, 4.6875 µg/mL, 
2.34375 µg/mL, and a blank negative control of 0 µg/mL. Muscle homogenate was 
allowed to thaw on ice while the standards were prepared. All muscle tissue samples 
were then diluted 1:20 using 15 µL of sample and 285 µL of PBS.  12000 µL of 1:50 
working reagent was made for the assay by combining 11764.7 µL reagent A with 235.3 
µL reagent B. This volume would allow enough working reagent for duplicates of the 
standards and unknown samples in a 96-well plate. 100 µL of standards and unknown 
samples were added to a 96-well clear bottom microplate, followed by 100 µL of 
working reagent. The plate was then sealed and incubated at 37.0 
o
C for 1 hour. 
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Figure 12:  Standard curve for BCA protein assay of soleus muscle tissue. All unknown 
samples had absorbencies within this standard curve that allowed for interpolation and 
subsequent determination of protein concentration, followed by multiplying by a dilution 
factor of 20. Recording absorbance at 562 nm yielded a best-fit standard curve of y = 
3.4009x + 0.1564, with R
2
 = 0.9799.  
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The assay was performed using a Molecular Devices SpectraMax Paradigm 
machine. Paradigm SMP was opened and connected to the machine via computer. ABS-
MONO was selected to begin the assay and the wavelength was set to 562 nm. The plate 
selected for the assay was defined as 96 Well Standard clrbtm. The reading area was 
highlighted and assignments were made to all standards and unknown samples. The plate 
was shaken on medium intensity for 5 seconds prior to reading absorbencies.  
A standard curve was prepared by plotting the average absorbance of the standards 
against the designated concentration. The concentration of unknown samples was 
calculated using the standard curve best-fit equation and multiplying by the dilution 
factor of 20. Once the concentration of each sample was determined, total protein content 
could be determined for appropriate future Magpix analysis. 
Absorbency data from Paradigm SMP were plotted and graphed in Excel to 
produce the standard curve. This curve was used for interpolation of sample protein 
concentration.  
 
Magpix 
Insulin in plasma samples were analyzed for comparison between LCR basal, 
LCR insulin-stimulated, HCR basal, and HCR insulin-stimulated groups at respective 
times directly preceding tissue harvest (t=0 min. for basal groups and t=120 min. for 
insulin-stimulated groups). In addition, insulin-stimulated groups of LCR and HCR rats 
were analyzed at both t=0 min. and t=120 min. Analysis protocol was carried out using 
the Rat Metabolic Magnetic Bead Panel by Milliplex® MAP Kit (Merck, Cat. 
#RMHMAG-84K). Antibody-immobilized beads were sonicated for 30 seconds and then 
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vortexed for 10 seconds. 150.0 µL of antibody was transferred and diluted in a mixing 
bottle with 2.85 mL of bead diluent (LE-BD). Quality controls 1 and 2 (RMH-6084) were 
reconstituted by adding 250.0 µL deionized water to each vial. These were vortexed and 
allowed to sit for 10 minutes before loading into a 96-well plate. Wash buffer (L-WB) 
was prepared by diluting 30.0 mL 10X wash buffer with 270.0 mL deionized water. 1.0 
mL deionized water was added to reconstitute serum matrix (LRGT-SM) and this was 
allowed to sit 10.0 minutes prior to loading. Standards were prepared by reconstituting 
the metabolic standard (RMH-8084) with 250.0 µL deionized water and vortexing for 10 
seconds. The vial was left to sit 10.0 minutes before performing serial dilutions to prepare 
a standard curve for the assay. 
Two hundred microliters of assay buffer (LE-ABGLP) was added to each well of 
a 96-well plate and shaken for 10 minutes at room temperature before decanting the 
buffer solution and adding 25.0 µL of serum matrix to each well. 25.0 µL assay buffer 
was then added to each well in addition to 25.0 µL of standards, controls, or unknown 
plasma samples. 25.0 µL of magnetic beads were added to each well before the plate was 
sealed, covered in aluminum foil, and incubated on a shaker at 4.0 
o
C for 18 hours.  
All reagents were allowed to come to room temperature before well contents were 
decanted. The plate was washed three times by first allowing the plate to rest upon a 
magnetic block for 60.0 seconds. Well contents were decanted, then the plate was washed 
with 200.0 µL wash buffer and shaken for 30 seconds at room temperature. After that, the 
plate was reattached to the magnet and allowed to sit for 60.0 seconds before again 
decanting. Immediately following the washing steps, 50.0 µL detection antibodies 
(RMH-1084) were added to each well. The plate was covered and shaken at room 
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temperature for 30.0 minutes. Then, without decanting, 50.0 µL Streptavidin-
Phycoerythrin ((L-SAPE12) was added to each well and the plate was again covered and 
shaken for 30.0 minutes at room temperature. The 96-well plate was then washed three 
times in the same way mentioned previously. Finally, 100.0 µL wash buffer was added to 
resuspend the beads before the plate was read using Luminex xPONENT (Merck) 
software. Data from Luminex xPONENT were analyzed as mean fluorescence intensity 
and were saved in Excel files for analysis. 
Total Akt and pAKT levels in each sample of muscle homogenate were also 
measured. A 2-plex total/phosphor Akt Magnetic Bead Kit (Cat. #48-618MAG) was used 
to analyze Akt content. To begin, reagents were prepared for the immunoassay per 
protocol guidelines. The 20x stock magnetic bead solution was sonicated for 15.0 
seconds and then vortexed for 30.0 seconds. The beads (42-618MAG) were diluted to 1x 
concentration by transferring 150.0 µL stock solution into a mixing bottle with 2.85 mL 
assay buffer 2 (43-041). The biotin-labeled antibody was prepared by vortexing a 20x 
stock solution (44-618MAG) for 10.0 seconds and diluting 150.0 µL in a mixing bottle 
with 2.85 mL assay buffer 2.  Streptavidin-Phycoerythrin (45-001H) was vortexed for 
10.0 seconds and diluted by combining 120.0 µL in a mixing bottle with 2.88 mL assay 
buffer 2. Control cell lysates (47-205 and 47-216) were each reconstituted with 100.0 µL 
Millipore® water before being vortexed gently and incubated for 5.0 min at room 
temperature. 150.0 µL assay buffer 2 was then added to each cell lysate vial and the vials 
were vortexed gently before use in the assay.  
All sample homogenate muscle concentrations were calculated using the standard 
curve. The samples were first allowed to thaw on ice before being diluted to 1.6 µg/µL 
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with working lysis buffer. Muscle samples were stored on ice per protocol 
recommendation. These samples were further diluted 1:1 with assay buffer 2 as suggested 
in the protocol, giving a final concentration of 20 µg in a 25 µL aliquot (20 µg / 25 µL 
after a 1:1 dilution with assay buffer 2). 
Fifty microliters of assay buffer 2 was added to each well of a clean 96-well plate. 
The plate was covered and shaken at room temperature for 10.0 minutes. Assay buffer 
was decanted and 25.0 µL of the vortexed 1x bead suspension was added to each well. 
Following bead addition, 25.0 µL assay buffer, controls, and muscle homogenate samples 
were added to appropriate wells. The plate was sealed, covered in aluminum foil, and 
shaken at 4.0 
o
C for 20 hours.  
Following cold incubation, the plate was washed with assay buffer two times as 
described previously. 25.0 µL of 1x detection antibody was added to each well and the 
plate was shaken at room temperature for 1 hour. The plate was attached to a magnetic 
block for 60.0 seconds and the antibody was decanted before the addition of 25.0 µL 
Streptavidin-Phycoerythrin to each well. The plate was again sealed and shaken for 15.0 
min at room temperature. Without decanting the Streptavidin-Phycoerythrin, 25.0 µL 
amplification buffer (43-024A) was added. The plate was sealed again and shaken for 
15.0 min at room temperature. Finally, the plate was attached to a magnetic block for 
60.0 seconds before decanting the Streptavidin-Phycoerythrin and amplification buffer. 
Beads were resuspended with the addition of 150.0 µL assay buffer 2 in each well. The 
plate was shaken for 5.0 minutes at room temperature before reading the plate with 
Luminex xPONENT software.  
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Data from Luminex xPONENT  were saved as mean fluorescence intensity and 
stored in an Excel file. 
 
Statistical Analysis 
Significance was initially set at α=0.05. Two-tailed student’s t-tests were 
performed on sample sizes greater than n=13 to compare body masses, food 
consumption, and rate of body mass increase. For in vivo data with small sample sizes, 
means were compared using Cohen’s d with 95% confidence intervals. As mentioned 
previously, findings that appeared significant were further supported with two-tailed 
student’s t-tests or wilcoxen-rank-sum to obtain p-values. Data are represented as mean 
+/- SEM.  
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RESULTS 
 
Body Weight Gain and Food Consumption 
Matching the rats based on body mass was a good way to exclude extraneous 
variables in the research design. Weight-matching the rats into separate groups yielded a 
negligible difference in mass at week 12 as well as at the time of tissue harvesting 
(Appendix A). Body weights were recorded weekly during a 12-week observational 
period, with LCR rats observed to have significantly higher body mass each week as 
compared to HCR rats, p<0.001 (Figure 13A).  
Ad-libitum food consumption was observed to be constant over 12-week 
observation for both LCR and HCR groups (Figure 13B). LCR and HCR absolute food 
consumption data appear to overlap each week, showing no difference in consumption 
(p=0.86). Over the 12-week observational period, LCR and HCR rat groups gained 
appreciable mass (Figure 13A); however, HCR rats appeared to consume more food 
relative to body mass than LCR rats (Figure 14). Further supporting this observation, the 
rate at which mass was gained (Figure 15) was greater in LCR rats as compared to HCR 
rats (p<0.05). These data begin to suggest that intrinsic aerobic capacity may be 
responsible for the observed differences in basal metabolic rate (also see Appendix B). 
Together, these data may indicate a few things:  HCR rats may have an increase in cage 
activity as compared to LCR rats, HCR rats may have heightened metabolic rate as 
compared to LCR rats, or the observed difference in basal metabolic rate between LCR 
and HCR rats may result from a combination of these suggestions. 
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Figure 13:  Body mass and food consumption during 12-week observation. A) Aerobic 
capacity influences body mass. LCR rats exhibited higher body masses than HCR rats 
during each week throughout the 12-week observation. Standard error bars are displayed 
for each week, with no overlap seen between groups. Both LCR and HCR rats appeared 
to have a positive rate of change in body mass. B) Food consumption did not differ 
between low and high aerobic capacity rat cohorts. Consumption appeared to be constant 
throughout 12-week observation with standard error bars shown to be overlapping 
(p=0.86), ***p<0.001. 
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Figure 14:  Food consumption of rat cohorts relative to body weight during 12-week 
observation. These data were transformed from figure 13, shown above. HCR rats 
appeared to consume more food relative to body weight than LCR rats, consistent 
throughout the entirety of observation.  
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
1 2 3 4 5 6 7 8 9 10 11 12
R
at
io
 
Time (weeks) 
HCR
LCR
 47 
 
Figure 15:  Side-by-side boxplots compare the rate of body mass change in low and high 
aerobic capacity rat models. Rate was calculated as total mass gained over time (g/week). 
It appeared there is a higher median rate of change in the LCR group (n=14) as compared 
with the HCR group (n=14). In addition, there appeared to be a slight positive skew in the 
HCR data as the median line is closer to the 75
th
 percentile than to the 25
th
 percentile. 
However, there did not appear to be any outliers in this dataset. The distribution of LCR 
appeared normal and without any outliers. The mean of each dataset were significantly 
different, *p<0.05. 
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Insulin Sensitivity is Reduced in LCR Rats During a Euglycemic-Hyperinsulinemic 
Clamp 
A euglycemic-hyperinsulinemic clamp was performed as previously described 
above. After a 5-hour fast, baseline blood glucose readings did not differ between LCR 
and HCR rats at t=-10 min and t=0 min (p=0.47 and p=0.32, respectively). At t=0 min. 
hematocrit readings were taken and compared to levels taken at t=120 min. to ensure 
similar and minimal blood loss during the clamp procedure. Reliable and effective clamp 
data will have minimal blood loss and no difference in blood loss between groups. This 
study observed on average a 13% decrease in hematocrit levels for LCR and HCR rats, 
with no significant difference in hematocrit decrease between LCR and HCR rats 
following the clamp (p=0.45, data not shown). A metabolic clamp proceeds over 120 
minutes with literature data suggesting a successful clamped value of blood glucose 
around 130 mg/dL, determined by the average value of the final few readings (Ayala et 
al. 2006). This supports a clamped value as being the average of values obtained between 
t=90 min. and t=120 min. Figure 16 shows the progression of blood glucose readings in 
LCR and HCR rats throughout the duration of the metabolic clamp procedure. There was 
no difference observed between LCR and HCR rat blood glucose levels between t=90 
min. and t=120 min. (p=0.86, Figure 16A). LCR rats were observed to have an average 
clamped value of 130.5 mg/dL whereas HCR rats had an average clamped value of 134.2 
mg/dL. These data yielded a Cohen’s d value of 0.1324 (-1.31, 1.56) which further 
suggest there was no difference in clamped blood glucose levels during LCR and HCR 
metabolic clamp procedures, as standard error bars overlap (Figure 16B).  
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Figure 16:  Blood glucose levels during metabolic clamp. Panel A) shows blood glucose 
levels during the metabolic clamp procedure. LCR (n=3) and HCR (n=5) rats had similar 
fasting glucose levels at t=-10 min. Blood glucose levels appear to follow a similar 
pattern as time progresses, eventually toward a targeted blood glucose reading of about 
130 mg/dL. Literature data suggest clamped values of blood glucose occur between t=90 
min. and t=120 min. During this time interval, no difference was observed between blood 
glucose readings for LCR and HCR rats as standard error bars overlap. Panel B) displays 
the mean (+/- standard error) clamped values for both LCR and HCR rats. Standard error 
bars overlap, suggesting there is no difference in values. When further comparing effect 
sizes, a Cohen’s d value of 0.1324 was obtained with a 95% confidence interval of (-1.31, 
1.56). 
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Glucose infusion rate was measured during the clamp procedure while rats were 
administered a constant infusion of insulin at 4 mU/kg/min. At t=30 min. there appears to 
start a difference in glucose infusion rate to maintain the clamped value of blood glucose 
concentration of 130 mg/dL (Figure 17A). Similar to the graph for blood glucose levels a  
clamped value of glucose infusion rate will be the average of the values recorded 
coinciding with the values used to determine the clamped value of blood glucose. In this 
study, the final 4 values of glucose infusion rate from t=90 min. through t=120 min. were 
used to determine a clamped value of glucose infusion. Figure 17A displays the 
progression of glucose infusion measurements throughout the duration of the metabolic 
clamp procedure. LCR rats were observed to have a clamped glucose infusion rate of 
24.25 μg/g/min and HCR rats were observed to require an increased glucose infusion rate 
of 31.35 μg/g/min (p<0.05). A Cohen’s d value of 1.856 (0.047, 3.569) was obtained for 
glucose infusion rate data, with no observed overlap in standard error bars (Figure 17B). 
Together, these data suggest that low intrinsic aerobic capacity causes insulin resistance. 
 
Low Aerobic Capacity Reduces Soleus Muscle Mass, But Not Total Akt Content 
There was no significant difference observed between soleus muscle mass in LCR 
and HCR rats (p=0.624). Error bars overlap with a 95% confidence interval of (-15.0, 
28.5), further supporting the observation that there was no difference in soleus muscle 
mass (Figure 18A). Relative to body mass, HCR rats were observed to have increased 
soleus muscle mass when compared to LCR rats (p<0.001). The ratio of soleus muscle 
mass to total body mass appeared to be increased 1.5-fold in HCR rats as compared to  
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Figure 17:  Glucose infusion rates during metabolic clamp. Panel A) displays the effect of 
aerobic capacity on glucose infusion rate. LCR (n=3) rats appeared to require lower rates 
of glucose infusion to maintain euglycemia during a clamp procedure than HCR (n=5) 
rats. Literature data suggest glucose infusion rate to be defined by the values recorded 
from t=90 min. through t=120 min. The data support a difference in average glucose 
infusion rate during these observations. Standard error bars are displayed for all time 
points with no observed overlap during t=100 min, t=110 min, nor t=120 min, which 
suggests a significant difference in glucose infusion rates. Panel B) displays the mean 
glucose infusion rate (+/- standard error) for LCR and HCR rats during the defined time 
points of t=90 min. through t=120 min. Standard error bars are displayed with no overlap, 
suggesting a significant difference between the two populations. Upon further 
comparison using effect sizes, a Cohen’s d value of 1.856 was obtained with a 95% 
confidence interval of (0.047, 3.569), *p<0.05. 
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Figure 18:  Aerobic capacity does not appear to directly influence soleus muscle mass, 
but may influence overall lean body mass. A) LCR rats (n=7) did not appear to have a 
significant difference in soleus muscle mass as compared to HCR rats (n=12). A p-value 
of 0.624 was obtained with 95% confidence interval of (-15.0, 28.5), which further 
suggests that aerobic capacity does not influence soleus muscle mass. B) Relative to 
overall body mass, HCR rats (n=12) exhibited a significantly greater proportion of soleus 
muscle mass as compared with LCR rats (n=7) which might suggest a role of intrinsic 
aerobic capacity in lean body mass, ***p<0.001. 
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LCR rats (Figure 18B). These data may suggest that high intrinsic aerobic capacity is 
associated with locomotor muscles as compared to low intrinsic aerobic capacity.  
As a measure of skeletal muscle insulin signaling, total Akt content was determined in 
both LCR and HCR rats (Figure 19). These data suggested no difference in total soleus 
muscle Akt content between LCR and HCR rats (p=0.482). A Cohen’s d value of 0.378 (-
0.568, 1.313) was obtained to further support the observation. Collectively these results 
indicate that while aerobic capacity might not influence total Akt in comparable samples, 
aerobic capacity is associated with the size of the soleus muscle. 
 
Aerobic Capacity and Skeletal Muscle Akt(Ser
473
) Phosphorylation Following 
Insulin Stimulation 
Plasma insulin concentrations were recorded in all groups immediately prior to 
tissue harvest. Aerobic capacity had no effect on LCR- and HCR-basal group insulin 
concentration (Figure 20A). Upon insulin stimulation, an increase in plasma insulin 
concentration was observed in HCR rats as expected (p<0.05). It appeared that LCR rats 
also had an increase in plasma insulin concentration upon insulin stimulation. For LCR 
rats, a Cohen’s d value of 2.174 (0.130, 2.174) was obtained. Since the 95% confidence 
interval does not include 0, these data suggest a significant increase in plasma insulin 
levels as a result of insulin stimulation. These data did not yield a p-value of less than 
0.05 only because variances were not assumed to be equal, it should be noted that the 
error bars do not overlap and that Cohen’s d confidence interval supports a difference. 
Taken together, these data support a difference in insulin concentration between basal  
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Figure 19:  Aerobic capacity does not appear to influence total Akt content within 
skeletal muscle tissue. Data are presented as the mean value +/- standard error. There was 
no significant difference observed in the total amount of Akt within soleus muscle tissue 
of LCR rats (n=7) and HCR rats (n=12). Statistical analysis yielded a Cohen’s d value of 
0.378 with a 95% confidence interval of (-0.568, 1.313). Error bars overlap with p=0.482 
and a 95% confidence interval of the difference in means being (-186.0, 336.63). 
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Figure 20:  Plasma insulin concentration at time of tissue harvest and during the 
metabolic clamp procedure. A) There appears to be a 4-fold increase in plasma insulin 
concentration between HCR basal (n=7) and HCR insulin (n=5) groups. Statistical 
analysis of effect sizes gives Cohen’s d value of -2.3268 (-3.821, -0.769). An apparent 5-
fold increase in plasma insulin concentration between LCR basal (n=4) and LCR insulin 
(n=3) yielded Cohen’s d value of 2.174 (0.130, 2.174). There was no observed difference 
between basal groups of LCR and HCR as Cohen’s d = 0.224 (-1.015, 1.451). Similarly, 
no difference was observed between insulin-stimulated groups of LCR and HCR as 
Cohen’s d = -0.373 (-1.804, 1.088). B) Plasma insulin concentration increased during the 
metabolic clamp procedure, yielding about a 3-fold increase in HCR rats [Cohen’s d = -
1.065 (-2.379, 0.304)] and a 2.5-fold increase in LCR rats [Cohen’s d = -1.268 (-3.021, 
0.601)] between t=0 min. and t=120 min. There did not appear to be a difference between 
HCR and LCR plasma insulin concentration neither at t=0 min. (-1.707, 1.172) nor t=120 
min. (-1.399, 1.464) which suggests similar clearance in plasma insulin, *p<0.05. 
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and insulin-stimulated groups while negating any difference in insulin administration 
between LCR and HCR rats. 
During the euglycemic-hyperinsulinemic clamp, HCR rats were observed to have 
an increase in plasma insulin concentration at t=120 min. when compared with t=0 min. 
(p<0.05, Figure 20B). Data suggest a 3-fold increase in plasma insulin concentration 
upon insulin administration throughout the clamp procedure. LCR rats appear likely to 
have observed an increase in plasma insulin at t=120 min. as compared with t=0 min. 
with a Cohen’s d value of -1.268 (-3.021, 0.601). The interval suggests a lack of 
significance, probably due to variance and small sample size; however, error bars do not 
overlap and there still appears to be a 2.5-fold increase in plasma concentration. Further, 
there was no difference between LCR and HCR insulin levels at either t=0 min. (-1.707, 
1.172) nor at t=120 min. (-1.1399, 1.464). Together, these data support a successful 
clamp procedure and suggest similar insulin clearance in both LCR and HCR rats. 
Insulin will cause phosphorylation of Akt at Thr
308 
and Ser
473
 before facilitating 
GLUT4 translocation to the membrane for glucose uptake. Insulin-stimulated HCR rats 
were observed to have an increase in pAkt as compared to basal HCR rats (p<0.05, 
Figure 21). This supports the expected observation upon insulin-stimulation.  
Insulin-stimulated LCR rats were observed to have a similar fold-change in pAkt 
levels as HCR counterparts, but the increase was not statistically significant. A Cohen’s d 
value for basal and insulin-stimulated LCR rats was calculated to be -1.1045 (-2.698, 
0.578).  Error bars appear to overlap even though mean values mimic HCR data. No 
difference was observed between HCR basal and LCR basal groups (-1.486, 1.159); no 
  
 57 
 
Figure 21:  Basal and insulin-stimulated pAkt in rats of low and high aerobic capacity. 
Data are shown as mean values +/- standard error. Upon insulin administration, there 
appears to be an increase in phospho-Akt (Ser
473
) between HCR basal (n=7) and HCR 
insulin-stimulated (n=5) groups. Statistical support is indicated with a Cohen’s d value of 
-1.306 and a 95% confidence interval of (-2.559, -0.001). In addition, an increase in 
phospho-Akt (Ser473) might exist between LCR basal (n=4) and LCR insulin-stimulated 
(n=3) groups with an observed Cohen’s d value of -1.1045 and 95% confidence interval 
(-2.698, 0.578). There was no statistical difference between LCR basal and HCR basal 
groups as effect size analysis yielded a Cohen’s d value of -0.2587 and a 95% confidence 
interval of (-1.486, 1.159). Further, there was no statistical difference between LCR 
insulin-stimulated and HCR insulin-stimulated groups as effect size analysis yielded a 
Cohen’s d value of -0.0508 and a 95% confidence interval of (-1.48, 1.38) *p<0.05. 
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difference was observed between insulin-stimulated groups of LCR and HCR rats (-1.48, 
1.38). This figure supports insulin as directly influencing Akt phosphorylation within 
soleus muscle tissue and begins to suggest that a difference in Akt phosphorylation might 
not depend on aerobic capacity in slow, oxidative muscle fibers. 
When pAkt data were normalized to total Akt levels, insulin-stimulated HCR rats 
had a greater proportion of pAkt as compared to basal HCR rats (p<0.05, Figure 22). 
LCR rats observed similar fold-changes in data; however, the increase was not 
statistically significant. The figure shows elevated levels of phspho-Akt (Ser
473
) relative 
to total Akt content in insulin-stimulated soleus muscle tissue of HCR rats (n=5) as 
compared to basal HCR rats (n=7). A Cohen’s d value of -0.7184 (-2.244, 0.872) might 
suggest that a true difference exists in normalized pAkt values observed between basal 
LCR and insulin-stimulated LCR rats. Further, there was no difference observed in 
normalized pAkt values between basal groups of HCR and LCR rats (-0.722, 1.785). 
There did not appear to be any significant difference in levels of phospho-Akt (Ser
473
) in 
insulin-stimulated soleus muscle tissue of LCR rats (n=3) as compared to basal LCR rats 
(n=4). No difference was observed between insulin-stimulated groups of HCR and LCR 
rats (-1.626, 1.246). Together, these data suggest that low aerobic capacity may hinder 
phosphorylation of Akt(Ser
473
) in insulin signaling pathways.  
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Figure 22:  Ratio of phospho-Akt (Ser
473
) to total Akt content within soleus muscle 
tissue. Data are presented as the mean value +/- standard error. No overlap of standard 
error occurs, and further analysis of effect sizes yielded a Cohen’s d value of -1.0654 
with 95% confidence interval (-2.279, 0.194). Statistical analysis using effect sizes 
showed a Cohen’s d value of -0.7184 with 95% confidence interval (-2.244, 0.872). 
Further, there was no observed difference between HCR basal and LCR basal groups as 
effect size analysis gave Cohen’s d value of 0.499 with 95% confidence interval (-0.722, 
1.785). No difference was observed between insulin-stimulated muscle tissue in LCR and 
HCR rats as effect size analysis yielded Cohen’s d value of -0.1982 with 95% confidence 
interval (-1.626, 1.246). *p<0.05 
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DISCUSSION 
 
Aerobic capacity is associated with insulin signaling in vitro, but limited evidence 
has been demonstrated in vivo (Lessard et al. 2011; Medeiros et al. 2010). Recent data 
supports Akt phosphorylation at Ser
473
 to be a key, proximal insulin signaling event 
related to insulin resistance in humans (Friedrichsen et al. 2010). Therefore, an 
association may exist between Akt phosphorylation and in vivo insulin sensitivity. The 
present study examined the effect of aerobic capacity on insulin sensitivity and skeletal 
muscle insulin signaling in conscious, unrestrained rat models of low and high aerobic 
capacities. The focus of this research was to ascertain whether proximal insulin signaling 
mechanisms, such as Akt phosphorylation at Ser
473
, are associated with systemic insulin 
resistance.  
Several factors limit this study. These include the following:  small sample size 
(n=3-5), mortality rate during surgical procedures, metabolic clamp complications, and 
sensitivity of signaling assays. Small sample sizes were largely due to mortality rate 
during surgery. It is interesting to note that HCR rats appeared to recover better from both 
catheterization and sham surgeries as compared to LCR rats (data not shown). During the 
clamp procedure, tubes disconnected the infusion pumps to catheters for a brief period of 
time during two IS metabolic clamps, but these were immediately reattached and 
measurements resumed. The euglycemic-hyperinsulinemic clamp procedure was 
effective in determining insulin sensitivity of rats completing the clamp proecedure (n=3-
5). However, one LCR-IS rat was excluded from the study because of complications 
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during this metabolic clamp procedure. These complications included blood loss from the 
arterial line and difficulty maintaining constant infusions of insulin and glucose.  
Another source of error may have been a result of establishing the phospho-
Akt/total Akt signaling assay in the Morris Lab. Trial runs with select samples did not 
initially produce expected fold-changes in phospho-Akt(Ser
473
) for positive controls. A 
new Akt signaling assay was used to troubleshoot the initial observations. The new kit 
produced a 1- or 2-fold increase in Akt phosphorylation (Ser
473
) from baseline to insulin-
stimulated samples. All remaining samples were then analyzed following this verification 
step.  
The results obtained support an association between low aerobic capacity and a 
greater rate of physiological weight gain (Figures 13, 14, And 15). LCR and HCR rats in 
this study began acclimation at 20+/-2 weeks of age. Body mass measurements began at 
22+/-2 weeks of age, with there already being a significant difference in mass between 
LCR and HCR rats. It is likely that HCR rats were more physically active within housing 
cages than LCR rats, thus contributing to differences observed in mass measurements. An 
increase in physical activity has been observed in HCR rats as compared to LCR rats 
following both normal chow and high-fat diets (Novak et al. 2010). Within skeletal 
muscle of LCR and HCR rats, an increase in physical activity was attributed to elevated 
levels of PEPCK-C in HCR rats as compared with LCR rats. This enzyme functions in 
gluconeogenesis and its overexpression is consistently linked with extended endurance 
and longevity (Novak et al. 2010). Thus, it is likely that this contributed to the lower 
observed body mass measurements in HCR rats.  
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Ad libitum food consumption was not different between groups (p=0.86), which 
suggests absolute caloric intake had no contribution to differences observed in body 
mass. Further, HCR rats consumed greater amounts of food relative to body mass each 
week as compared with LCR rats. HCR rats consistently weighed less with increased 
food consumption per gram of body weight throughout the duration of the study (Figure 
14). These data may suggest a greater basal metabolic rate in HCR rats as compared to 
LCR rats. Furthermore, the rate of physiological body mass increase was significantly 
less in HCR rats than LCR rats (Figure 15). Together, these data support an inherent 
difference in physiological weight gained between LCR and HCR rats. Therefore, 
elevated energy expenditure due to physical activity and higher basal metabolic rates in 
HCR rats could be linked to improved energy homeostasis and decreased body weight as 
compared to LCR rats.  
These data support previous observations suggesting the association between 
physical inactivity and obesity (Tremblay and Willms 2003). Exercise training has been 
associated with increases in working aerobic capacity over a defined time interval and 
metabolic enzymatic adaptations (Henriksson and Reitmann 1977). Together, these data 
begin to suggest physical inactivity might be associated with lower levels of working 
aerobic capacity, which can lead to increased weight gain and increased risk of obesity. 
In addition, HCR rats had increased insulin sensitivity in vivo through use of a 
euglycemic-hyperinsulinemic clamp (Figure 17). This clamp procedure is a ―gold-
standard‖ when determining insulin sensitivity (Ayala et al. 2011). LCR rats were 
observed to be less insulin-sensitive as compared to HCR rats. The higher observed body 
weights in LCR rats as compared with HCR rats may contribute to these observations. As 
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mentioned before, the final four time values, t=90-120 min., were used when determining 
the mean value of glucose infusion rate (GIR). At t=30 min. GIR (mg/kg/min) began to 
diverge between LCR and HCR rats (Figure 17A). The lower GIR (mg/kg/min) observed 
in LCR rats is indicative of systemic insulin resistance. Together, these data show aerobic 
capacity influences GIR (mg/kg/min) in response to a constant infusion of insulin.  
A reduction in GIR suggests LCR rats are more insulin resistant than HCR rats. 
The reduction in glucose uptake begins to mimic a TIIDM phenotype, which may support 
insulin resistance as a link between physical inactivity and diabetes (Campbell and Reece 
2005). Previous studies consistently link physical activity with improved insulin 
sensitivity (Lessard et al. 2011; Medeiros et al. 2010; Hamilton et al. 2014). To determine 
which part of the insulin signaling pathway was responsible for the reduction in glucose 
uptake, soleus muscle tissues were analyzed for total and phosphorylated Akt content, 
since Akt phosphorylation is imperative for insulin-stimulated skeletal muscle glucose 
uptake (Gonzales and McGraw 2009; Stanford and Goodyear 2014; Figure 23). 
Magpix protein assays helped determine the impact of aerobic capacity on 
skeletal muscle Akt phosphorylation in vivo (Figures 20, 21, and 22). Our hypothesis was 
that LCR rats would have impaired Akt phosphorylation that accompanies the observed 
decrease in GIR. HCR rats were observed to have an increase in Akt phosphorylation 
upon insulin-stimulation while LCR rats did not demonstrate the same significant 
increase in Akt phosphorylation when stimulated with insulin. Aerobic capacity does not 
appear to significantly influence the total amount of Akt present within the cell (Figure 
20). However, intrinsic aerobic capacity appears to influence the consistency of phospho-
Akt(Ser
473
)  and the ratio of phospho-Akt(Ser
473
) / total Akt in HCR rats. Significant 
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increases in absolute and normalized Akt phosphorylation were not observed in LCR rats 
(Figures 21 and 22, respectively). Therefore, the observed increase in Akt 
phosphorylation in HCR rats is not simply due to an increased amount of Akt. Instead, 
these data begin to suggest a reduction in the consistency of Akt phosphorylation in LCR-
IS rats. 
Akt phosphorylation is known to increase upon insulin administration (Bruss et al. 
2005). Given this observation, these data suggest that LCR rats may have impairments in 
Akt phosphorylation relative to HCR rats. Taken together, these data might be interpreted 
to suggest the difference in systemic insulin sensitivity observed between LCR and HCR 
rats is mediated through a difference in Akt signaling. Figures 21 and 22 show a 
significant increase in phospho-Akt(Ser
473
) in HCR-IS rats, but not in LCR-IS rats. 
However, neither basal nor insulin-stimulated levels of phospho-Akt(Ser
473
) were 
significantly different between LCR-IS and HCR-IS rats (Figures 21 and 22). These 
observations do imply a convincing argument for any impairment in insulin-stimulated 
Akt phosphorylation. Mean values of total Akt and pAkt did not differ between LCR-IS 
and HCR-IS rats, which may indicate intact insulin signaling at the level of Akt 
phosphorylation. 
The lower value of GIR observed in LCR rats could be attributed to other 
mechanisms involved in glucose homeostasis. These may include elevated liver glucose 
production or impaired delivery of substrate to insulin-stimulated skeletal muscle. 
Together, these data do not provide a convincing argument to suggest low aerobic 
capacity is associated with impairments in Akt phosphorylation. Thus, the reduction in 
GIR observed in LCR rats might be attributed to a reduction in protein activation 
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downstream Akt. A good direction for future studies may be to focus on expression and 
activation of TBC1D1, AS160, and GLUT4 (Figure 23). 
Small sample sizes likely contributed to high variability in Akt signaling. 
Standard error bars overlapped in data presentation of total Akt (Figures 21 and 22), and 
increasing sample sizes would reduce standard error. The 95% confidence interval around 
Cohen’s d was (-0.568, 1.313), which includes 0 and is interpreted as not being 
significant. However, the upper end of this range may indicate a significant difference 
exists. Similarly, reducing the observed error in phospho-Akt(Ser
473
) through an increase 
in sample size might strengthen the data (Figures 21 and 22).  
Future studies include replicating results and increasing sample sizes. Impaired 
insulin-stimulated phosphorylation of Akt could lead to impairments in insulin-stimulated 
GLUT4 translocation to the membrane for glucose uptake. Other insulin-stimulated 
targets of interest include phosphorylation of AS160 or TBC1D1. These distal 
phosphorylation steps have been implicated in both insulin-stimulated and contraction-
induced glucose uptake in muscle (Cartree et al. 2007, Taylor et al. 2008). If these data 
were replicated and absolute values of Akt phosphorylation did not differ between LCR 
and HCR rats, then the impairment in insulin-stimulated glucose uptake must occur distal 
to Akt phosphorylation. Skeletal muscle glucose uptake is influenced by insulin-
stimulation as well as compensatory pathways influenced through exercise (Figure 23). 
Glucose uptake and exercise-mediated GLUT4 translocation is not impaired during acute 
bouts of exercise in mice lacking skeletal muscle insulin receptors (Stanford and 
Goodyear 2015). These findings may provide future avenues for understanding the  
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Figure 23:  Exercise and insulin regulation of glucose transport (Stanford and Goodyear 
2015). This figure highlights insulin signaling for glucose uptake and proposes several 
compensatory mechanisms for GLUT4 translocation upon an exercise-induced increase 
in skeletal muscle contraction.  
  
 67 
mechanisms responsible for the observed LCR reduction in GIR as compared to HCR 
rats.  
These results require further study to clarify the role of aerobic capacity in 
skeletal muscle insulin signaling during glucose uptake. Akt phosphorylation will be 
analyzed in vastus lateralis (type II fiber) and plantaris (type I and type II fibers) muscle 
tissues. If a difference in signaling activity is observed, a proteomic assay will be 
performed to assess phosphorylation activity of several metabolic proteins within the cell.  
Consistent with previous studies, our data support LCR rats have higher rates of 
physiological weight gain compared to HCR rats. LCR rats also had lower GIR during a 
euglycemic-hyperinsulinemic clamp as compared to HCR rats. This clamp procedure has 
been performed previously in mice (Ayala et al. 2011) and has now been established in 
LCR and HCR rats. This rat model has become a powerful tool in exploring potential 
epigenetic mechanisms of metabolic abnormalities. Insulin signaling was measured using 
Akt as a marker for pathway activity. Akt was selected because it is known to become 
phosphorylated upon insulin-stimulation and provides just one of many indications of 
insulin responsiveness (Bruss et al. 2005). Total Akt and phospho-Akt (Ser
473
) were 
measured using a multiplex ELISA that allowed for detection of both antibodies within a 
single sample. Therefore, the assay reduced error from multiple samples and gave a novel 
approach to protein detection within muscle samples. LCR-IS rats showed a reduction in 
fold-change expected from insulin-stimulation in both absolute and normalized phospho-
Akt(Ser
-473
) as compared to HCR-IS rats; however, the mean values of total Akt and 
phospho-Akt(Ser
473
) were not different between LCR-IS and HCR-IS rats. This may 
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imply distal impairments in glucose uptake, including activation of AS160, TBC1D1, or 
total GLUT4 expresison.  
To recapitulate, the mechanism(s) linking physical inactivity, diabetes, and 
obesity are still unclear; however, insulin resistance is observed in each phenomena and 
might be what links these three together. An unbiased, heterogeneous rat model was used 
to elucidate the impact of functional aerobic capacity on physiological weight gain, 
systemic insulin sensitivity, and insulin-stimulated glucose uptake. Rats of low and high 
aerobic capacities provided groups that mimic low and high levels of physical fitness. 
Data suggested low aerobic capacity, and therefore lower levels of physical fitness, were 
associated with increased physiological weight gain and reductions in insulin sensitivity 
as compared to high aerobic capacity, or those with higher levels of physical fitness. 
Together, these findings imply an association between physical inactivity, obesity, and 
diabetes through reductions in insulin sensitivity. However, insulin signaling data are yet 
inconclusive in determining where there is impairment in insulin-stimulated skeletal 
muscle glucose uptake (Figures 20, 21, and 22). Future studies may confirm insulin 
resistance at the level of Akt in other skeletal muscle fiber types (vastus lateralis type II, 
plantaris type I and II) or suggest distal impairments in insulin-stimulated glucose uptake.  
In short, insulin resistance appears to be a linking mechanism between diabetes, 
physical inactivity, and obesity. We used a nonbiased rat model to assess the impact of 
aerobic capacity on insulin-stimulated glucose uptake and Akt activity. The results begin 
to suggest a difference in Akt activity between LCR and HCR rats; however, the data are 
not yet convincing to make a definite conclusion of insulin signaling impairment at that 
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level. Thus, future studies will either confirm impairment at Akt or suggest distal 
impairment in insulin-stimulated glucose uptake. 
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APPENDICES 
 
Appendix A 
 
Group assignments of LCR and HCR Rats 
Group Mass(g)* 
Surgery 
Mass(g) 
Clamp Mass(g) ΔMass 
Age 
(days) 
HCR 
Catheterization 
377.7 377 370.6 6.4 - 
404.3 410.2 370 40.2 - 
486.8 518.5 502.6 15.9 308 
399.2 420 408 12 286 
472.7 507 - - 330 
472.6 499.9 474.5 25.4 298 
374.6 395.5 - - 326 
HCR 
Sham/Basal 
403.2 400.6 392.9 7.7 247 
400.9 420.5 389.6 30.9 277 
471.6 482.2 480.8 1.4 305 
383.7 392.3 383.9 8.4 277 
481.5 510 479.4 30.6 339 
463.1 479.1 474 5.1 322 
384 411.2 408.5 2.7 354 
LCR 
Catheterization 
532.8 540 528 12 280 
509.3 526.6 408.2 118.4 296 
605.7 637.6 602.5 35.1 303 
507.6 523.4 507.5 15.9 302 
597.6 625.6 - - 321 
485.8 509.4 463.5 45.9 338 
495.2 525.9 - - 312 
LCR Sham/Basal 
531 531.1 - - 303 
531.5 532.5 448.2 84.3 267 
559.7 596.8 - - 300 
540.8 565 563.2 1.8 288 
472.3 488.1 - - 338 
576.1 608 515.5 92.5 344 
525 553.1 545.1 8 335 
This table displays group assignments for surgical groups. Rats were weight-matched to 
reduce variables. The * refers to mass measurement taken after 12-week observation, 
which determined group placement. Actual mass refers to measurement taken on surgery 
day while clamp mass refers to mass taken the morning of the euglycemic-
hyperinsulinemic clamp. Clamp mass was the final mass taken before tissue harvesting. 
Change in mass was recorded to support adequate recovery from surgery and ages are 
displayed to support a negligible effect of age on surgical procedures and data collection. 
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Appendix B 
Fecal samples were collected by Dr. Tyler Morris at the Jordan Valley Innovation 
Center. Total DNA was extracted using Qiagen QiAmp DNA Stool Mini Kit and was 
quantified using Nanodrop 2000 before subsequent dilution to 10 ng/µL. The protocol 
was modified slightly to yield a higher ratio of bacterial DNA to host DNA. About 50 ng 
DNA was loaded into a PCR reaction that targeted bacterial 16s rRNA variable regions 
V2 and V3 for species-specific identification. A 40 bp GC clamp was incorporated for 
purposes of separation in subsequent gel staining. After product verification, the samples 
were loaded into denaturing gradient gel electrophoresis (DGGE). The gel was then 
stained with Ethidium Bromide and imaged using UV transillumination.  
From the gel image below, a similarity matrix was constructed using Phoretix 
software. Based on the similiarities, the UPGMA dendrogram below was constructed to 
show relationships between organismal microflora in LCR and HCR rats. These data 
suggest that aerobic capacity does not influence gut microflora. A similarity matrix was 
constructed with no less than 79% similarity between LCR and HCR samples. These data 
may further support the role of aerobic capacity within the cell, affecting mitochondrial 
dynamics or insulin signaling pathways. The observed difference in metabolism may 
therefore be attributed to aerobic capacity and cannot be associated with microflora 
composition.   
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Gut microflora composition of LCR and HCR rats. Panel A) DGGE fingerprint generated 
from HCR and LCR samples. Lanes are as follows: (1) HCR - 19.6; (2) HCR - 19.14; (3) 
HCR – 19.7; (4) HCR – 19.13; (5) LCR – 19.16; (6) LCR – 19.27; (7) LCR – 19.18; (8) 
LCR – 19.21. Panel B) UPGMA dendrogram from fecal samples. This representation 
classifies and groups sample lanes on the basis of band presence/absence similarities. 
Panel C) Similarity matrix generated using Dice similarity index. The boxes shaded in 
green denote the comparisons within HCR samples, the Red boxes show comparisons 
within LCR samples, and the Blue boxes compare HCR samples to LCR samples. 
 
